Back to SNDX
Prosight Management, LP → SNDX
Prosight Management, LP SNDX Position History
Syndax Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$15.3M
Q3 2026
Peak value
$26.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $14M |
| Q1 2026 | $18M |
| Q2 2026 | $26.2M |
| Q3 2026 | $15.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $15.3M | 812.6K | — | — |
| Q2 2026 | $26.2M | 1.20M | — | — |
| Q1 2026 | $18M | 770.0K | — | — |
| Q4 2025 | $14M | 665.0K | — | — |
Other funds holding SNDX
$188.1M
$169.2M
$153.2M
$123.7M
$123.7M
$118.9M
$116.1M